The largest database of trusted experimental protocols

12 protocols using anti cd90 pe

1

Hypoxia-Induced BMSC Viability Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total bone marrow cells were flushed from the femurs and tibias of rats (2- to 4-month-old) with culture medium; the rats were sacrificed via sevoflurane overdose as previously described [31 (link)]. Complete L-DMEM containing 15% FBS, 100 U/ml penicillin, and 100 U/ml streptomycin was used to resuspend the BMSCs, and then, the BMSCs were incubated in a humid chamber. At 48 h, the first medium change was performed to remove the nonadherent cells. When the cells reached 90% confluence, they were harvested with 0.25% trypsin (Sigma) and passaged at a ratio of 1 : 2. FCM was performed to assess the BMSC surface markers. The cells were incubated with the following fluorochrome-conjugated primary antibodies (all from BioLegend, USA): anti-CD90-PE, anti-CD29-APC, and anti-CD45-PE. BMSCs from passage (P) 3 to P5 were used for subsequent experiments.
The cells were stimulated with hypoxia, and cell viability was detected [32 (link)]. Approximately 5 × 105 BMSCs suspended in L-DMEM were plated in 150 mm-diameter culture dishes. The cells were then separately cultured under the conditions below for 12, 24, 48, 72, 96, or 120 h: 10% exosome-free FBS with hypoxia (94% N2, 5% CO2, and 1% O2 gas mixture). BMSC viability was analyzed with CCK-8 assays. Briefly, adherent cells were digested with 0.05% trypsin and collected for CCK-8 assay according to the manufacturer's instructions.
+ Open protocol
+ Expand
2

Immunoblotting and FACS Analysis of Chondrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal anti-type II collagen (CIIC1, 1:500) and anti-STRO1 (STRO1, 1:100) antibodies were obtained from the Developmental Studies Hybridoma Bank, University of Iowa. For western blotting, monoclonal α-tubulin (T6199, 1:2,000, Sigma-Aldrich), anti-SMAD2/3 (c-8, sc-133098, 1:1,000), anti-SMAD1 (A-4, sc-7965, 1:1,000), anti-SOX9 (H-90, sc-2095, 1:1,000), anti-RUNX2 (M-70, sc10758, 1:1,000), anti-SMAD4 (B-8, sc-7966, 1:1,000), anti-TGF-β3 (III, sc-83, 1:100), anti-collagen type I (C-18, sc-8784, 1:100), and anti-ALK1 (c20, sc-19547, 1:100) antibodies were from SC Biotechnology. Polyclonal anti-phospho-SMAD2 (Ser465/467, #3101, 1:1,000) purchased from Cell Signaling Technology, and anti-ALK5 antibodies (Ab-165, E11-1126B, 1:100) from EnoGene Biotech. FACS analysis was performed with PE-coupled anti-CD29 (#554543, 1:500), CD34 (#345802, 1:200), CD106 (#551146, 1:500), and fluorescein isothiocyanate (FITC)-coupled anti- CD45 (#345808, 1:200), CD105 (#312404, 1:500) antibodies from BD Pharmingen. Anti-CD90-PE (#328110, 1:200) was from BioLegend. All secondary antibodies were the ones used previously (Koelling et al., 2009 (link)).
+ Open protocol
+ Expand
3

Immunofluorescent Characterization of RA FLS

Check if the same lab product or an alternative is used in the 5 most similar protocols
RA FLS were grown to 90% confluence on 8-well glass chamber slides. Cells were fixed with 1% Formalin and blocked with Fc block (10% human serum/10% mouse serum in PBS). Cells were incubated for 1hour at room temperature with anti-CD13-FITC (1D7) 1μg/100μl and anti-MMP14-PE (clone128527, R&D, Minneapolis, MN) 1.67μg/100μl or anti-CD90-PE 1μg/100μl (3E10, Biolegend, San Diego, CA). All experiments also included staining with MsIgG isotype controls (MsIg-FITC [eBiosciences, San Diego, CA], MsIg-PE [Biolegend, San Diego, CA]) at the same concentrations. The nuclei were counter stained with DAPI at 1μg/ml. Cells were mounted using Pro-gold anti-fade media (Life Technologies, Carlsbad, CA). Images were taken with an Olympus Fluo-View 500 confocal microscope system (University of Michigan Microscopy and Image Analysis Core) at 600x and1000x. All images were corrected for background, thresholds were determined by DAPI alone, MsIg-FITC alone, and MsIg-PE alone. Co-localization was analyzed with ImageJ using the plug-in “Colocalization”, by Pierre Bourdoncle, Institut Jacques Monod, Service Imagerie, Paris.
+ Open protocol
+ Expand
4

Immunophenotypic Characterization of hFM-MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
hFM-MSCs at the third passage were analyzed by flow cytometry (Attune NxT Flow Cytometer, Thermo Fisher Scientific) to verify their immunophenotypic profile. The antibodies used were: for hematopoietic markers (anti-CD14-allophycocyanin (APC), anti-CD34-fluorescein isothiocyanate (FITC) (Becton Dickinson), and anti-CD45-peridinin chlorophyll protein complex (PerCP) (Becton Dickinson)); for an endothelial-perivascular marker (anti-CD31-phycoerythrin (PE) (Becton Dickinson)); for stromal markers (anti-CD44-FITC (Biolegend), anti-CD73-PE (Becton Dickinson) and anti-CD90-PE (Biolegend)); and for the major histocompatibility complex class II (anti-HLA-DR-PE (Becton Dickinson)).
+ Open protocol
+ Expand
5

Multicolor Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were incubated for 30 min with or without conjugated specific antibodies at recommended concentrations at 4°C. Then cells were washed, resuspended in PBS, and analyzed on a Flow Cytometer (DxFLEX, Beckman). Unlabeled cells were used as blank control. The antibodies included anti-CD29 (FITC) (102,205, BioLegend), anti-CD45 (Alexa Fluor 647) (202,211, BioLegend), and anti-CD90 (PE) (202,523, BioLegend).
+ Open protocol
+ Expand
6

Characterization of Murine BMMSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Five cell surface markers (Sca-1, CD90, CD73, CD34 and CD45) were examined. BMMSCs were trypsinized and counted to ensure each sample had more than 1×105 cells. The cells were incubated with antibody anti-Sca-1(FITC) (eBioscience, USA), anti-CD90 (PE) (Biolegend), anti-CD73(FITC) (eBioscience, USA), anti-CD34(PE) (Biolegend, USA) and anti-CD45(PE) (BD Biosciences, USA) for 30 min at room temperature. Then cells were washed twice and suspended for flow cytometry.
+ Open protocol
+ Expand
7

Isolation and Culture of Rat BMSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolation and culture of BMSCs were performed according to a previously published protocol but with minor modifications.46 Briefly, young rats were rapidly anaesthetized with sevoflurane and sacrificed by dislocating cervical vertebrae. BMSCs were collected from the femur and tibia by flushing the medullary canal with Dulbecco's Modified Eagle Medium (DMEM)/F12 (Gibco). The medium was centrifuged at 1500 rpm for 5 min to isolate the BMSCs. The cells were resuspended in 4 mL DMEM/F12 containing 10% foetal bovine serum (Clark) and cultured in 25 cm2 culture flasks in an incubator (Sanyo) at 37°C and 5% CO2. The cells were detached with 0.25% trypsin‐ethylenediaminetetraacetic acid (EDTA) (Gibco) when they reached 90% confluence. Passage 3 (P3) cells were identified using flow cytometry (BD Bioscience) as described previously,34 using the following antibodies: anti‐CD29‐FITC, CD45‐FITC, anti‐CD90‐PE and anti‐CD11b‐PE (all from BioLegend). Well‐growing cells at passages 3–8 were used in subsequent experiments.
+ Open protocol
+ Expand
8

Characterization of Human Bone Marrow-Derived Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Healthy human bone marrow-derived mesenchymal stem cells (BM-MSCs, passage 3) were purchased (Gibco, #A15652) and cultured in low-glucose DMEM (Thermo Fisher Scientific, #11054020) supplemented with 10% Fetal Bovine Serum (FBS - Pan Biotech, #P30-3306), 1% L-glutamine (2 mM, Sigma Aldrich, #G7513) and penicillin/streptomycin antibiotic solution (100 U/0.1 mg/ml, Sigma Aldrich, #P4333) at 37 °C degrees containing 5% CO2 in humid environment. For the evaluation of cell surface markers, cells were detached with trypsin-EDTA (Thermo Fisher Scientific, #25300054), collected by centrifuging at 300 X G for 5 minutes, and then suspended in Dulbecco’s phosphate buffered saline (DPBS) containing 0.1% sodium azide. Next, the cells were labeled with anti-CD73 FITC (Clone:AD2, Biolegend, #344016), anti-CD90 PE (Clone: 5E10, Biolegend, #328110), anti-CD105 PerCP/Cy5.5 (Clone:43A3, Biolegend, #323216), anti-CD34 PE/Cy7 (Clone:581, Biolegend, #343515), anti-CD11b Alexa Fluor 700 (Clone:ICRF44, Biolegend, #301355), anti-HLA-DR Pacific Blue (Clone:L243, Biolegend, #307633), and anti-CD45 (Clone: J33, Beckman Coulter, #A96416) antibodies by incubating under dark conditions for 15 minutes at room temperature. The cells were immediately acquired on Beckman Coulter DxFLEX flow cytometry system. Analyses were performed on CytExpert software.
+ Open protocol
+ Expand
9

Hematopoietic Stem Cell Assay and Genotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Frozen healthy or patient BM samples were stained with anti-CD123–Brilliant violet 421, anti–CD38-FITC, anti–CD90-PE, anti-lineage markers (CD3, CD4, CD8, CD11b, CD14, and GPA)–Tricolor, anti–CD34-PE-Cy7, anti–CD127-biotin, and anti–CD45RA-APC-Cy7 antibodies (BioLegend, BD, or Invitrogen). Subsequently, biotin was detected by streptavidin-APC (eBioscience). CD34+lin cells were sorted into methylcellulose (H4230; STEMCELL Technologies) containing 20 ng/ml IL-3, 10 ng/ml IL-6, 10 ng/ml IL-11, 10 ng/ml SCF, 50 ng/ml TPO, 4 U/ml EPO, 50 ng/ml GM-CSF, and 10 ng/ml Flt3L (PeproTech), and cultured for 12–15 d, followed by colony classification and isolation of gDNA from single colonies with the QIAamp DNA Micro kit.
+ Open protocol
+ Expand
10

Phenotypic Characterization of PL-hMSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The phenotype of PL-hMSCs was evaluated by flow cytometry (FACScalibur™, Becton Dickinson, USA) and CellQuest® software (Becton Dickinson, USA). Native third to fifth passages of PL-hMSCs were trypsinized using 0.25% trypsin-EDTA and suspended in PBS. Cells were incubated with fluorochrome-labeled mouse anti-human monoclonal antibodies: anti-CD45-FITC (Bio Legend, USA), anti-CD34-PE (Biolegend, USA), anti-CD90- PE (Bio Legend, USA), anti-CD73-PE (Bio Legend, USA), and anti-CD105-PE (BD Bioscience, USA) for 30 min at 4 °C in the dark. After incubating with the antibodies, cell pellets were washed twice with PBS and fixed with 1% (w/v) paraformaldehyde in PBS.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!